NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens
dc.contributor.author | Viswanathan, K | |
dc.contributor.author | Beg, S | |
dc.contributor.author | He, B | |
dc.contributor.author | Zhang, T | |
dc.contributor.author | Cantley, R | |
dc.contributor.author | Lubin, DJ | |
dc.contributor.author | Shi, Q | |
dc.contributor.author | Maleki, Z | |
dc.contributor.author | Asiry, S | |
dc.contributor.author | Rao, R | |
dc.contributor.author | Katabi, N | |
dc.contributor.author | Nakaguro, M | |
dc.contributor.author | Faquin, WC | |
dc.contributor.author | Sadow, PM | |
dc.contributor.author | Siddiqui, MT | |
dc.contributor.author | Scognamiglio, T | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2023-04-27T16:04:26Z | |
dc.date.available | 2023-04-27T16:04:26Z | |
dc.date.issued | 2022-01-01 | |
dc.identifier.issn | 0002-9173 | |
dc.identifier.issn | 1943-7722 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/34508546 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176224 | en |
dc.description.abstract | Objectives: Salivary gland acinic cell carcinoma (AciCC) has recognizable cytomorphologic features that can overlap with benign and malignant entities, creating a diagnostic challenge. AciCC harbors a t(4;9) translocation increasing nuclear receptor subfamily 4 group A member 3 (NR4A3) expression, detectable by immunohistochemistry (IHC) on surgical resection (SR). NR4A3 IHC cytology data are limited. Here, we examine NR4A3 IHC on smears, cell blocks (CBs), and SRs of AciCC and its mimickers. Methods: Our cohort comprised AciCC (including high-grade transformation), secretory carcinoma, mucoepidermoid carcinoma (MEC), Warthin tumor, pleomorphic adenoma (PA), cellular PA, carcinoma ex-PA, oncocytic carcinoma, oncocytoma, and nodular oncocytosis. NR4A3 IHC (Santa Cruz Biotechnology and Origene antibodies) was positive if more than 5% tumor cells showed nuclear staining. Results: Among CBs, 90% of AciCC cases and none of the mimickers expressed NR4A3. Among SRs, 100% of AciCC cases showed diffuse NR4A3, whereas one high-grade MEC expressed focal NR4A3. Concordance was 95% with two antibody clones. Sensitivity, specificity, positive predictive value, and negative predictive value were 90%, 100%, 100%, and 94.7% for CBs and 100%, 98.8%, 92.3%, and 100% for SRs, respectively. NR4A3 immunostaining was demonstrable on smears from an AciCC case. Conclusions: NR4A3 IHC can be a robust diagnostic tool to identify AciCC, especially for cytology specimens. | |
dc.format.medium | ||
dc.language | eng | |
dc.publisher | Oxford University Press (OUP) | |
dc.subject | Acinic cell carcinoma | |
dc.subject | NR4A3 | |
dc.subject | Oncocytic | |
dc.subject | Salivary | |
dc.subject | Biomarkers, Tumor | |
dc.subject | Carcinoma, Acinar Cell | |
dc.subject | Carcinoma, Mucoepidermoid | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Humans | |
dc.subject | Immunohistochemistry | |
dc.subject | Receptors, Steroid | |
dc.subject | Receptors, Thyroid Hormone | |
dc.subject | Salivary Gland Neoplasms | |
dc.title | NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens | |
dc.type | Article | |
dc.identifier.pmid | 34508546 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176224/2/aqab099.pdf | |
dc.identifier.doi | 10.1093/ajcp/aqab099 | |
dc.identifier.doi | https://dx.doi.org/10.7302/7163 | |
dc.identifier.source | American Journal of Clinical Pathology | |
dc.description.version | Published version | |
dc.date.updated | 2023-04-27T16:04:20Z | |
dc.identifier.orcid | 0000-0003-0031-0001 | |
dc.identifier.orcid | 0000-0002-0409-2374 | |
dc.identifier.orcid | 0000-0003-3273-4802 | |
dc.identifier.orcid | 0000-0002-5776-8366 | |
dc.identifier.volume | 157 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 98 | |
dc.identifier.endpage | 108 | |
dc.identifier.name-orcid | Viswanathan, K; 0000-0003-0031-0001 | |
dc.identifier.name-orcid | Beg, S | |
dc.identifier.name-orcid | He, B | |
dc.identifier.name-orcid | Zhang, T | |
dc.identifier.name-orcid | Cantley, R | |
dc.identifier.name-orcid | Lubin, DJ; 0000-0002-0409-2374 | |
dc.identifier.name-orcid | Shi, Q | |
dc.identifier.name-orcid | Maleki, Z; 0000-0003-3273-4802 | |
dc.identifier.name-orcid | Asiry, S | |
dc.identifier.name-orcid | Rao, R; 0000-0002-5776-8366 | |
dc.identifier.name-orcid | Katabi, N | |
dc.identifier.name-orcid | Nakaguro, M | |
dc.identifier.name-orcid | Faquin, WC | |
dc.identifier.name-orcid | Sadow, PM | |
dc.identifier.name-orcid | Siddiqui, MT | |
dc.identifier.name-orcid | Scognamiglio, T | |
dc.working.doi | 10.7302/7163 | en |
dc.owningcollname | Pathology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.